NYSE:IBO | Cash Flow Statement | IMPACT BIOMEDICAL INC.

Complete source-backed cash-flow history.

Available history
2022-06-30 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$699,000.00
2026-03-31-$2.29M$285,000.00-$464,000.00-$1,000.00$482,000.00
2025-12-31$5.25M$286,000.00$99,000.00$1,000.00
2025-09-30-$1.47M
2025-06-30-$14.35M
2025-03-31-$1.27M$283,000.00-$682,000.00$1,000.00
2024-12-31-$27.11M$279,000.00-$986,000.00$0.00$317,000.00
2024-09-30$4.25M
2024-06-30-$889,000.00
2024-03-31-$962,000.00$280,000.00-$482,000.00$483,000.00
2023-12-31-$1.19M$280,000.00-$433,000.00$1,000.00$232,000.00
2023-09-30-$1.18M
2023-06-30-$1.12M
2023-03-31-$849,000.00$280,000.00-$1.01M-$4,000.00$1.02M
2022-12-31-$3.37M$278,000.00-$363,000.00-$275,000.00$539,000.00
2022-09-30-$2.24M
2022-06-30-$799,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$11.84M$1.15M-$1.89M$3,000.00-$109,000.00
2024-12-31-$24.71M$1.12M-$2.85M$2,000.00$4.85M
2023-12-31-$4.34M$1.12M-$2.85M-$15,000.00$2.87M
2022-12-31-$7.26M$1.11M-$2.24M-$349,000.00$2.55M